Background: Ventricular fibrillation (VF) storm after myocardial infarction (MI) is a life-threatening condition that necessitates multiple defibrillations. Catheter ablation is a potentially effective treatment strategy for VF storm refractory to optimal medical treatment. However, its impact on patient survival has not been verified in a large population. Methods: We conducted a multicenter, retrospective observational study involving consecutive patients who underwent catheter ablation of post-MI refractory VF storm without preceding monomorphic ventricular tachycardia. The target of ablation was the Purkinje-related ventricular extrasystoles triggering VF. The primary outcome was in-hospital and long-term mortalities. Univariate logistic regression and Cox proportional-hazards analysis were used to evaluate clinical characteristics associated with in-hospital and long-term mortalities, respectively. Results: One-hundred ten patients were enrolled (65±11years; 92 men; left ventricular ejection fraction [LVEF] 31±10%). VF storm occurred at acute phase of MI (4.5±2.5 days after the MI onset during index hospitalization for MI) in 43 (39%) patients, subacute (>1 week) in 48 (44%), and remote (>6 months) in 19 (17%). The focal triggers were found to originate from the scar border zone in 88 (80%) patients. During in-hospital stay after ablation, VF storm subsided in 92 (84%) patients. Overall, 30 (27%) in-hospital deaths occurred. The duration from the VF occurrence to the ablation procedure was associated with in-hospital mortality (odds ratio for each one-day increase: 1.11; 95% confidence interval [CI]: 1.03-1.20; p=0.008). During follow-up after discharge from hospital, only one patient developed recurrent VF storm. However, 29 (36%) patients died with a median survival time of 2.2 years (interquartile range: 1.2-5.5 years). Long-term mortality was associated with LVEF<30% (hazard ratio [HR]: 2.54; 95%CI: 1.21-5.32; p=0.014), New York Heart Association class ≥III (HR: 2.68; 95%CI: 1.16-6.19; p=0.021), a history of atrial fibrillation (HR: 3.89; 95%CI: 1.42-10.67; p=0.008), and chronic kidney disease (HR: 2.74; 95%CI: 1.15-6.49; p=0.023).
Clinical Perspective

What is new?
• This multicenter study evaluating the largest consecutive series of patients undergoing catheter ablation for refractory ventricular fibrillation (VF) storm after myocardial infarction (MI) indicates that ablation of the focal Purkinje-related triggers frequently arising from the scar border-zone at the left ventricular septum appears to be associated with short-and long-term freedom from VF storm recurrence.
• Early intervention after VF storm occurrence may lead to a reduced risk of in-hospital cardiovascular mortality.
• Long-term follow-up outcome is limited by steady increases in both cardiovascular and non-cardiovascular mortalities that are associated with severity of underlying cardiovascular disease and comorbidities.
What are the clinical implications?
• Patients with MI presenting with focally-triggered VF storm refractory to medical therapies should be transferred to a dedicated critical care unit to optimize the overall condition of these patients and to perform ablation as early as possible.
• Our observation regarding the dominant domain of VF triggers may serve as a roadmap for ablation to target the culprit Purkinje network at the specific regions.
• Careful management of heart failure and comorbidities in this specific population is of great importance, even in cases where the electrical storm subsides after catheter ablation.
Introduction
Myocardial electrical storm represents a life-threatening, malignant condition of clustering ventricular arrhythmias that necessitate multiple defibrillations. Ventricular fibrillation (VF) storm attributed to focally-triggered VF after myocardial infarction (MI) could be recognized as a distinctive arrhythmic syndrome with specific pathophysiology and lethal characteristics that differs from scar-mediated monomorphic ventricular tachycardia (VT) (1) . The initial approach to patients presenting with VF storm is usually focused on exclusion of myocardial ischemia and administration of antiarrhythmic medications. However, antiarrhythmic drugs may fail to suppress VF or may be limited by contraindications or adverse effects (e.g., long QT interval, hyperthyroidism, and/or labile hemodynamic compensation and severe dysfunction of the left ventricle) (1, 2) . The condition often requires other therapies combined with antiarrhythmic medications, including deep sedation with mechanical ventilatory support, overdrive pacing, and/or hemodynamic support devices to stabilize patients. Neuraxial modulation with thoracic epidural anesthesia may be also effective for electrical storm management (3, 4) . However, despite these extensive therapeutic efforts, suppression of lethal arrhythmias can be transient.
Over the last two decades, radiofrequency catheter ablation has emerged as a potentially effective treatment strategy for post-infarct VF storm. The current guideline endorses catheter ablation for the management of therapy-resistant ischemic VF storm (5) . The main targets for ablation are identifiable focal triggers of VF. The pathogenic role of the Purkinje system is very high; discrete excitations act as main triggers of VF in patients with diseased hearts (6) .
The role of Purkinje fibers in VF maintenance is less documented than its role in VF initiation. Nevertheless, several experimental studies have revealed Purkinje in fibrillatory wave fronts during VF (7), and computer models showed migratory re-entrant activity at the Purkinje-muscle junction as a mechanism for maintaining early VF (8, 9) . Previous reports demonstrated an acute benefit of radiofrequency catheter ablation targeting specific Purkinje potentials that precede the triggers of VF (10) (11) (12) (13) . However, these reports were single center series evaluating a small number of patients. The impact of VF storm ablation on patient survival has not been verified in a large population. Therefore, we sought to investigate the acute and long-term outcomes of catheter ablation for the treatment of last resort in a large series of consecutive patients with post-MI VF storm refractory to medical therapies.
Methods
The data, analytical methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedures.
Study Population
Between January 2003 and May 2017, a total of 110 consecutive patients with VF storm following MI underwent radiofrequency catheter ablation as a last resort for refractory VF storm in 15 international tertiary care arrhythmia centers. VF storm was defined as ≥3 separated episodes of VF in 24 hours. Only patients with VF without preceding monomorphic ventricular tachycardia (VT) were included. VF storm was documented on bedside or telemetry monitors, device interrogation, or Holter recordings. The diagnosis of MI was based on medical history, clinical findings, and coronary angiography. All patients were brought to the intensive care unit and were managed by a combination of therapies, including coronary revascularization, antiarrhythmic medications, correction of electrolytes, deep sedation with mechanical ventilatory support, overdrive pacing, and/or circulatory support devices (extracorporeal membrane oxygenation and intra-aortic balloon pumping) at the discretion of the dedicated unit physicians.
When life-threatening conditions due to VF storm remained despite optimal medical therapies, the decision to transfer patients to the electrophysiological laboratory for catheter ablation was made by the dedicated cardiac team. All patients or families provided written informed consents of the ablation procedures. The institutional review boards of the participating centers approved the collection of data. This study included 29 patients who had been included in previous studies (13) (14) (15) .
Mapping and Ablation Strategy
The number and type of catheters varied in individual centers and individual patients. Multipolar catheters were positioned from the femoral veins into the right ventricle and at the His bundle.
Mapping and ablation of the left ventricle was performed by the transaortic (retrograde) or the transseptal approach. Three-dimensional electroanatomic mapping was performed using CARTO (Biosense Webster, Diamond Bar, CA) or NavX (St. Jude Medical, St. Paul, MN). A non-irrigated-tip catheter or an irrigation catheter was used for mapping and ablation. Systemic heparinization was maintained during mapping and ablation. General anesthesia with mechanical ventilatory support was used as part of the previous therapy or periprocedurally at the discretion of the operator.
The targets of ablation were the ventricular premature beats (VPBs) triggering VF.
Purkinje potentials that preceded the onset of the triggering VPBs were frequently found around the scar border zone and were carefully identified (11) (12) (13) . Additionally, pace mapping was performed to localize ablation targets. In these respects, it was essential to document the triggering VPBs on a 12-lead ECG prior to the ablation procedure. When no spontaneous VPBs were detected during the ablation procedure, they were induced by pacing maneuvers (ventricular burst or extrastimuli) with the addition of an intravenous isoproterenol (3.0-5.0 μg/min) or epinephrine (5-10 μg) infusion. Radiofrequency energy was delivered with a maximum power of 40 W and a target temperature of 42°C for the irrigation catheter and 55°C
for the non-irrigated catheters. The inducibility of VF and VT was tested at the end of procedure at the operator's discretion. When attempted, pacing was performed from the RV apex with up to triple extrastimuli decrementing down to 200 ms or to refractoriness, whichever occurred first.
The procedural end point was the elimination of all clinical triggering VPBs.
In-Hospital and Long-Term Follow-Up
Following the ablation procedure, patients were brought back to the intensive care unit and monitored. Intensive management to optimize the overall conditions of patients was continued following ablation procedure. Post-procedural medical treatment included beta-blockers and antiarrhythmic drugs, anticoagulation, revascularization, and management of heart failure with ventilatory support, intravenous catecholamine, hemodiafiltration, and circulatory support devices, as necessary. Patients who had no previous implantable cardioverter defibrillator (ICD) were implanted with the device before hospital discharge, with the exception of 5 patients who refused implantation. ICD programming was commonly set to include three zones: a VT zone (150-188 beats per minute; anti-tachycardia pacing attempts followed by shock), fast VT zone (188-210 beats per minute; 1 attempt of ATP and subsequently shock), and VF zone (>210 beats per minute; shock only, with antitachycardia pacing during charging, if available). Drug management and device programming during follow-up was at the discretion of the investigators.
Following hospital discharge, all recruiting centers were contacted for each patient. In addition to records of clinical events, electrocardiogram, and Holter monitoring, VF and associated intracardiac electrograms were documented by ICD interrogation logs.
Statistical Analysis
Categorical variables were expressed as numbers and percentages, and were compared using Cox proportional hazards analysis was used to assess the association of clinical and procedural variables on all-cause mortality following hospital discharge, from which hazard ratios (HR) and 95% CIs were derived. Cumulative incidence curves were plotted for recurrent VF/VT, all-cause mortality, cardiovascular deaths, non-cardiovascular deaths, and death from unknown reason. All tests were 2-tailed. A probability value of <0.05 was considered statistically significant.
Statistical calculations were performed with IBM SPSS Statistics 21.0.
Results
Patient Characteristics
Patient characteristics are summarized in Table 1 Eight patients underwent catheter ablation prior to coronary revascularization because of the following reasons: 1) 6 patients had remote phase of MI with chronic total occlusion and presented with VF storm without the evidence of acute infarction; 2) the remaining 2 patients with subacute MI had diffuse multi-vessel stenosis after coronary artery bypass grafting (Supplemental Table 1 ).
Acute Results of Ablation
Ninety-four (86%) patients presented to the laboratory with frequent, spontaneous VPBs. 
In-Hospital Outcomes
A flow diagram of in-hospital outcomes following ablation is shown in Figure 2 . After the first ablation procedure, VF storm subsided in 92 (84%) patients. However, despite ablation, VF Figure 3 . Ablation of VF storm resulted in a substantial reduction of the lethal ventricular arrhythmia burden.
Overall, there were 30 (27%) in-hospital deaths with a median survival time of 7 days
[IQR: 2-17 days]. Table 2 shows the clinical and procedural variables associated with in-hospital death. Of note, the duration between the occurrence of VF storm and the ablation procedure was significantly associated with in-hospital death (for each one-day increase; OR: Table 2 . While short-term mortality was mainly due to cardiovascular reasons (mostly refractory heart failure), long-term mortality was due to both cardiovascular (13 patients) and non-cardiovascular (11 patients) reasons. Non-cardiovascular causes included sepsis, cancer, and stroke. The cumulative incidences of overall mortality, cardiovascular-related and non-cardiovascular-related deaths after the index ablation procedure are shown in Figure 5B .
Cumulative incidence curve of all-cause mortality had a steep slope at the beginning mainly due to cardiovascular death, but there was a steady increase of non-cardiovascular death as well as cardiovascular death over long-term follow-up. In Cox regression analysis ( At least one hospitalization because of acute heart failure occurred in 17 (21%) patients, which led to death in 9 patients. Over the follow-up period, 4 (5%) patients developed a stroke.
Six (8%) patients underwent percutaneous coronary intervention for recurrent MI without VF storm.
Discussion
This multicenter study reviewed the largest consecutive series of patients undergoing catheter ablation for therapy-resistant VF storm following MI. The data indicated that catheter ablation targeting the focal Purkinje-related triggers frequently arising from the scar border-zone at the left ventricular septum was acutely effective in suppressing VF storm in most cases; however, despite ablation, uncontrollable VF storm occurred in 16% of patients. In-hospital death occurred in 27% of patients. Uncontrollable VF storm was associated with a high risk of subsequent death, and besides severity of heart failure, time from the beginning of the storm to catheter ablation were associated with acute mortality. When ablation resulted in acute survival from a VF storm, patients only developed sporadic events of recurrent VF over the long follow-up period.
However, a steady increase in mortality was noted during that period, which was associated with poorer clinical status including LVEF <30%, NYHA class ≥ III, and a history of atrial fibrillation and chronic kidney disease.
The Timing of the Catheter Ablation Procedure
In clinical practice, ablation of VF storm is usually implemented as a last-resort strategy;
however, the question regarding the optimal timing of catheter ablation remains. Although VF storm uncontrollable by ablation placed the patients at an extremely high risk of subsequent acute mortality, single isolated episodes of recurrent VF were neither associated with in-hospital death nor long-term mortality. On the other hand, the delay between the onset of the storm and ablation was associated with poor acute outcome. This is in part because of the prolonged exposure to electrical storm, which can further compromise the cardiac function and result in worsened overall conditions of patients. In this regard, the attempt to use catheter ablation for the management of VF storm (not for single isolated episodes of VF) in patients after revascularization and medical therapies should be considered earlier. The experience suggests that patient with VF storm should be transferred to a dedicated critical care unit that involves not only electrophysiologists who are experienced in VF/VT ablation but also specialists for managing heart failure, coronary interventionists, thoracic surgeons, and cardiac anesthesiologists to optimize the overall condition of these patients and to perform ablation as early as possible.
Strategy of Catheter Ablation
The primary goal of current ablation strategy for focally-triggered VF is to eliminate the Purkinje-related ectopic focus. Therefore, determining the earliest Purkinje potentials preceding the target ectopic beats is the key to successful ablation. As the pro-arrhythmic and pro-fibrillatory effects of beta-adrenergic stimulation have been demonstrated in the setting of investigations are needed to assess the prognostic significance of noninducibility after ischemic VF ablation.
Acute and Long-Term Outcomes
Previous studies on smaller patient cohorts demonstrated encouraging outcomes of VF storm ablation, wherein nearly all patients achieved elimination of VF storm and were discharged from the hospital alive (10) (11) (12) (13) . This study provided a realistic appreciation of ablation outcomes in VF storm. Patients presenting with VF storm often have multiple comorbidities including heart failure decompensation, multiple coronary artery diseases, diabetes mellitus, atrial fibrillation, and renal dysfunction. Peri-procedural management of heart failure decompensation and hemodynamic optimization with mechanical support when clinically indicated is of great importance, even in cases where urgent catheter ablation had successfully suppressed the electrical storm.
After patients survived the acute phase of VF storm, most of them remained free from recurrent VF, as observed over the long follow-up period. This is in contrast to a prior report investigating outcomes of ablation for scar-mediated VT, where the VT recurrence remained steady over 3 years post-ablation (22) . This is probably related to different characteristics of arrhythmia mechanisms. While patients with VF storm present with focal Purkinje arrhythmogenicity at the specific endocardial areas around the scar border, VT patients often have multiple coexisting VT circuits surrounded by large scars at the endocardium, epicardium, and/or deep within the myocardium, which may make a durable suppression of VT recurrence difficult to achieve in the long-term.
Previous studies have reported that the recurrence of VT after ablation of scar-mediated VT predicts a poor prognosis in the short-and long-terms (23) (24) (25) (26) (27) . This most probably reflects progressive heart failure associated with a worsened hemodynamic state due to irrepressible VT and negative inotropic consequences of ICD shocks for VT. Consistent with these previous studies on VT population, early recurrence of VF storm in this study was strongly associated with subsequent in-hospital death. These findings support the notion that acute suppression of VF storm by catheter ablation reduces cardiovascular mortality in the short-term. Furthermore, the long-term freedom from recurrent electrical storm may be associated with a reduced cardiovascular mortality. However, a gradual increase in long-term mortality occurred despite a low rate of recurrent life-threatening arrhythmias. While heart failure was the dominant cause of in-hospital death, long-term mortality was due to both cardiovascular and non-cardiovascular reasons and was not associated with the acute outcomes of ablation. These results underscore the importance of careful management over a long follow-up period globally beyond the use of catheter ablation.
Study Limitations
This study was not randomized and, hence, subject to the limitations inherent to observational studies. Although all patients in this study required multiple defibrillations for VF storm that was refractory to coronary revascularization and antiarrhythmic agents, the pre-procedural therapies were not uniform. The referral for catheter ablation might be influenced by the severity of arrhythmia burden and the overall conditions of patients. However, it would be difficult to conduct large randomized trials in this specific patient population because of the lethal characteristics as well as relative scarcity of cases with refractory VF storm after MI. Thus, non-randomized observational studies with a large population could be the way to serve as a source of evidence.
In this study, no patients used left ventricular assist devices that could be of potential benefit to improve the hemodynamic state, which might affect the timing of the ablation procedure. Furthermore, none of the patient underwent heart transplantation procedure. As most of patients in this study had end-stage intractable heart failure, heart transplantation may have improved their survival rates and functional statuses. Urgent catheter ablation may be performed as a bridge to heart transplantation in these sickest patients.
We also acknowledge the limited clinical data available from this observational study due to the potential substantial heterogeneity of procedures and techniques used during the ablation and management of patients after ablation. Long-term outcomes were available only in 80 (73%) patients who were discharged hospital alive. Furthermore, this study was not able to capture changes in ICD programming during follow-up. ICD re-programming according to type of recurrent arrhythmias may influence the mortality outcome (28) .
Conclusions
In patients with MI presenting with focally-triggered VF storm refractory to medical therapies, catheter ablation targeting the culprit triggers is life-saving and appears to be associated with short-and long-term freedom from recurrent VF storm. The triggering ectopic activities most commonly originate from the surviving Purkinje tissue over the border zone of ischemic scar in the left ventricular septum. Early intervention after the occurrence of VF storm may lead to a reduced risk of in-hospital cardiovascular mortality. However, the outcome over long-term follow-up is limited by steady increases in both cardiovascular and non-cardiovascular mortalities. The poor long-term prognosis reflects primarily severity of underlying cardiovascular disease and comorbidities in this specific patient population. 
